Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple video ease the fear of breast cancer surgery?

NCT ID NCT05350527

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether giving patients personalized, secure access to a web platform with an explanatory video about their upcoming breast cancer surgery can lower their anxiety. Participants are women with breast cancer scheduled for lumpectomy, oncoplasty, or mastectomy. The platform provides round-the-clock access to practical information and a surgery explanation video, aiming to reduce preoperative anxiety compared to standard information alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized web platform with explanatory video
What this could lead to
If effective, this approach could offer a simple, low-cost way to ease anxiety for people awaiting breast cancer surgery.
What could go wrong
This is a small, early-stage study, so results may not apply broadly. The platform may not significantly reduce anxiety compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

89 people

The number who actually took part.

Started

Jun 2022

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Histologically confirmed breast cancer. * Indication of breast lumpectomy, oncoplasty or mastectomy. * Person over 18 years old Exclusion Criteria: * Person with a history of breast cancer surgery. * Person with severely impaired physical and/or psychological health, which, in the opinion of the investigator, may affect the participant's compliance to the study. * Individuals who have difficulty understanding the French language orally. * Person who does not have Internet access at home or at work. * Person placed under court protection. * Person who is not a member or beneficiary of a national health insurance system. * Person who has not given oral informed consent after a reflection period. * Person participating in another research study with an exclusion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Béziers

    Béziers, France

  • CHU de Montpellier

    Montpellier, 34295, France

  • CHU de Nîmes

    Nîmes, 30029, France

  • Clinique de Clémentville

    Montpellier, 34000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.